North America Enteral Feeding Formulas Market Research Report 2016-2021
Posted by rohan on November 2nd, 2017
The North America Enteral Feeding Formulas Market was worth USD 880 million in 2016 and estimated to be growing at a CAGR of 7.8%, to reach USD 1.29 billion by 2021. A growing number of hospitals and ambulatory care services are embracing enteral nutrition as an effective system of clinical nutrition.
Enteral nutrition, or commonly referred to as “tube feeding”, is a liquid formula providing macronutrients (carbohydrates, proteins, and fats), micronutrients (vitamins and minerals), and water, all components necessary for sustaining life. Enteral nutrition formulas are supplied to a patient by way of a tube either through the nose, ending in the stomach or intestines (used for short-term needs), or a tube surgically placed directly into the stomach or small intestines (used for long-term needs).
The North America enteral feeding formulas market owing to rise in number of chronic disease patients, rapid aging population and surging prevalence of preterm birth, the market is projected to grow during the forecast period. However, factors such as complications associated with enteral nutrition, patient safety risks, and the occurrence of feeding and medication errors are expected to restrain the growth of the enteral feeding formulas market to a certain extent.
On the basis of product, the market is segmented into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas. Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the market is segmented into adults and pediatrics. On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the enteral feeding formulas market in 2015, primarily due to the high prevalence of malnutrition among cancer patients. By end user, the market is segmented into hospitals and long-term care facilities. Long-term care facilities are further divided into homecare agencies & hospices, nursing homes, and assisted living facilities. On the basis of geography, the North America market is analysed under various regions namely United States and Canada.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/north-america-enteral-feeding-formulas-devices-market-3332/request-sample
Some of the prominent players in the North America enteral feeding formulas market are Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).
4) End Users
Reasons to buy North America Enteral Feeding Formulas Market Research Report:
About Market Data Forecast:
Like it? Share it!
About the Authorrohan
Joined: September 20th, 2017
Articles Posted: 1,346
More by this author